ITGB4 and central nervous system cancer: In our experimental model, D-2HG demonstrated potential anti-glioma effects by inhibiting the expression of Integrin subunit beta 4 (ITGB4), which subsequently downregulated the phosphorylation levels of PI3K and AKT, ultimately suppressing glioma cell proliferation and promoting apoptosis.